Skip to search formSkip to main contentSkip to account menu

Imagopaque

National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

iopentol

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1997
1997
Iopentol (Imagopaque® 300) compared with iopromide (Ultravist® 300) in abdominal CT A multi-centre monitoring trial assessing adverse events and diagnostic information – results from 518 patients in…
Abstract.Objectives: Iopentol (Nycomed Imaging AS, Oslo, Norway) and iopromide (Schering AG, Berlin, Germany) are low-osmolar… 
1997
1997
Iopentol (Imagopaque® 300) compared with ioxaglate (Hexabrix® 320) in knee arthrography A clinical trial assessing immediate and late adverse events and diagnostic information
Summary.Objectives. This trial was designed to compare the incidence of delayed postprocedural pain after administration of… 
1997
1997
Iopentol (Imagopaque® 350) compared with diatrizoate (Urografin® 370) in cerebral CT A clinical trial assessing immediate and late (7 days) adverse events and diagnostic information (visualization…
Summary. The non-ionic contrast medium iopentol (Imagopaque®, Nycomed Imaging AS, Oslo, Norway) 350 mg I/ml was compared for… 
Review
1997
Review
1997
Iopentol (Imagopaque®) in vascular procedures A multi-centre monitoring trial assessing adverse events and diagnostic information – results from 3,587 patients in Germany
Abstract. The aims of the present open, non-comparative survey were to study the safety and efficacy of iopentol (Imagopaque… 
1997
1997
Delayed CT of the kidneys after iopentol (Imagopaque® 350) injection in patients with normal renal function An assessment of the gradual decrease in opacification over 32 h after injection
Abstract. The elimination of the non-ionic contrast medium iopentol (Imagopaque®, Nycomed Imaging AS, Oslo, Norway) from the… 
1997
1997
Iopentol (Imagopaque® 250) compared with diatrizoate (Urografin® 219) in endoscopic retrograde cholangio-pancreatography (ERCP) A clinical trial assessing safety (adverse events and S-pancreatic iso…
Summary. The efficacy and safety of the non-ionic contrast medium iopentol, 250 mg I/ml (Imagopaque®, Nycomed Imaging AS, Oslo… 
1997
1997
Cardiovascular and electrocardiographic effects of iopentol in left ventricular angiography Comparison of the low-osmolar, non-ionic iopentol (Imagopaque® 350) and the hyper-osmolar, ionic metrizoate…
Abstract. The aim of the study was to evaluate and compare the hemodynamic and electrocardiographic effects following injection… 
1997
1997
Iopentol (Imagopaque® 300) compared with iohexol (Omnipaque® 300) and diatrizoate (Urografin® 292) in pediatric urography A clinical trial assessing adverse events and diagnostic information
Summary. A double-blind, parallel-group trial was performed in 96 children in order to evaluate and compare the safety and… 
1997
1997
Iopentol (Imagopaque® 350) compared with iohexol (Omnipaque® 350) in pediatric cardioangiography A clinical trial assessing adverse events, ECG, blood pressure and diagnostic information
Summary. A non-ionic, monomeric, low-osmolar contrast medium, iopentol (Imagopaque®, Nycomed Imaging AS, Oslo, Norway) has been… 
1994
1994
Nonionic Contrast Media in Pediatric CT
In pediatric radiology there is a great demand for a safe contrast medium. In this pediatric CT trial, the safety, tolerability… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)